Compare Liquidia Corporation Common Stock (LQDA) vs Vanguard Dividend Appreciation Index Fund ETF (VIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? Liquidia Corporation Common Stock trades at $33.38 (market cap $3.04B), while Vanguard Dividend Appreciation Index Fund ETF trades at $242.02 (market cap $132.40B). The key difference: Vanguard Dividend Appreciation Index Fund ETF is far larger — about 43.6× Liquidia Corporation Common Stock's market cap, and Vanguard Dividend Appreciation Index Fund ETF is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Vanguard Dividend Appreciation Index Fund ETF for 134 Days on average.
| LQDA | VIG | |
|---|---|---|
Market Cap | $3.04B | $132.40B |
Volume | 21,111,778 | 893,381 |
Sector | Health | — |
52-Week High | $91.03 | $246.61 |
52-Week Low | $22.02 | $210.70 |
Typical Hold Time | 0 Days | 134 Days |
Enterprise Value | $2.94B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VIG trades at $241.81, up 0.88% with a bullish technical signal from moving averages, though RSI_6 at 90.76 suggests overbought conditions. The ETF focuses on dividend growth companies with 10+ years of consecutive dividend increases, offering a lower yield but stronger growth profile compared to peers like SCHD. Recent dividend of $0.93 was declared for September 2026 payment.
Outlook remains positive given VIG's historical 10% annual returns and quality focus, but risks include slow dividend growth and exclusion of high-yield stocks. The ETF suits long-term investors seeking reliable dividend growth over high current income, with technical support at $239.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Vanguard Dividend Appreciation Index Fund ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →
